Correlation Between Jinhe Biotechnology and Aier Eye
Specify exactly 2 symbols:
By analyzing existing cross correlation between Jinhe Biotechnology Co and Aier Eye Hospital, you can compare the effects of market volatilities on Jinhe Biotechnology and Aier Eye and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jinhe Biotechnology with a short position of Aier Eye. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jinhe Biotechnology and Aier Eye.
Diversification Opportunities for Jinhe Biotechnology and Aier Eye
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Jinhe and Aier is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Jinhe Biotechnology Co and Aier Eye Hospital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aier Eye Hospital and Jinhe Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jinhe Biotechnology Co are associated (or correlated) with Aier Eye. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aier Eye Hospital has no effect on the direction of Jinhe Biotechnology i.e., Jinhe Biotechnology and Aier Eye go up and down completely randomly.
Pair Corralation between Jinhe Biotechnology and Aier Eye
Assuming the 90 days trading horizon Jinhe Biotechnology Co is expected to generate 1.1 times more return on investment than Aier Eye. However, Jinhe Biotechnology is 1.1 times more volatile than Aier Eye Hospital. It trades about -0.01 of its potential returns per unit of risk. Aier Eye Hospital is currently generating about -0.12 per unit of risk. If you would invest 447.00 in Jinhe Biotechnology Co on October 26, 2024 and sell it today you would lose (14.00) from holding Jinhe Biotechnology Co or give up 3.13% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Jinhe Biotechnology Co vs. Aier Eye Hospital
Performance |
Timeline |
Jinhe Biotechnology |
Aier Eye Hospital |
Jinhe Biotechnology and Aier Eye Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Jinhe Biotechnology and Aier Eye
The main advantage of trading using opposite Jinhe Biotechnology and Aier Eye positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jinhe Biotechnology position performs unexpectedly, Aier Eye can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aier Eye will offset losses from the drop in Aier Eye's long position.Jinhe Biotechnology vs. Beingmate Baby Child | Jinhe Biotechnology vs. FSPG Hi Tech Co | Jinhe Biotechnology vs. Zhejiang JIULI Hi tech | Jinhe Biotechnology vs. Heilongjiang Transport Development |
Aier Eye vs. Bank of China | Aier Eye vs. Kweichow Moutai Co | Aier Eye vs. PetroChina Co Ltd | Aier Eye vs. Bank of Communications |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
CEOs Directory Screen CEOs from public companies around the world | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Fundamental Analysis View fundamental data based on most recent published financial statements |